BlossomHill Therapeutics raises $150M in IPO

Part of story

BlossomHill Therapeutics raises $150 million in upsized oncology IPO

Oncology-focused biotech firm BlossomHill Therapeutics raised $150 million in an upsized U.S. initial public offering, though shares fell 1.6% in their trading debut.

Aug 7, 20262 sources

BlossomHill Therapeutics raises $150 million in upsized oncology IPO

00

Other sources for this story

Bloomberg

Cancer Drugmaker BlossomHill Declines After $150 Million US IPO

Featured Stories

OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns

Aug 7, 20262 sources